Infectious Diseases Practice Questions

Q: What is the primary objective of the National STI Control Program?

Prevention and control of STI transmission. ***Prevention and control of STI transmission*** - The fundamental goal of the National STI Control Program is to **minimize the spread** of sexually transmitted infections. - This involves strategies to **reduce incidence** and **prevalence** through various public health interventions. *Research on new treatments* - While research is important for advancing STI management, it is typically a **secondary or supporting activity**, not the primary objective of a control program. - The main focus of a control program is on **direct public health impact** through existing knowledge and tools. *Contact tracing only* - **Contact tracing** is a critical component of STI control, but it is one strategy among many. - It is not the sole objective; comprehensive programs include **education, testing, and treatment**. *Providing free medications* - **Providing free medications** is a crucial part of accessible treatment, which contributes to control efforts. - However, it's a *means to an end* rather than the overarching primary objective, which is the **prevention and control of transmission**.

Q: Why is partner notification crucial in STI control?

To break the chain of transmission. ***To break the chain of transmission*** - **Partner notification (PN)** identifies and treats individuals potentially infected through sexual contact with an index patient, thereby preventing further spread of the **STI**. - This proactive approach ensures that asymptomatic or unaware partners are diagnosed and treated, effectively interrupting the continuous cycle of **STI transmission** within a community. *To improve compliance* - While PN can encourage partners to seek testing and treatment, its primary goal is not patient compliance with an existing treatment regimen. - Compliance improvement is usually addressed through direct patient education and follow-up, rather than through notifying sexual partners. *To track resistance patterns* - Tracking resistance patterns involves laboratory surveillance of STI pathogens through culture and sensitivity testing, which is separate from the public health intervention of partner notification. - PN focuses on identifying infected individuals for treatment, not on monitoring the antimicrobial susceptibility of circulating strains. *To reduce treatment costs* - Although widespread treatment through PN might reduce the long-term societal burden of STIs and associated complications, its direct and immediate purpose is not cost reduction. - The primary aim is disease control and prevention of severe health outcomes, even if initial costs for testing and treatment might increase.

Q: What is the most effective method for preventing sexual transmission of HIV?

Complete abstinence. ***Complete abstinence*** - **Abstinence** from sexual activity entirely eliminates the risk of sexually transmitted HIV, making it the most effective preventive measure. - As HIV is primarily transmitted through the exchange of bodily fluids during sexual contact, the absence of such contact prevents transmission. *Consistent condom use* - While highly effective when used correctly and consistently, **condoms can fail** due to breakage, incorrect use, or non-use, hence not 100% effective. - It significantly reduces the risk but does not eliminate it entirely, as there's still potential for exposure if a condom is not used at every sexual encounter or if there is contact with infected fluids outside the condom. *Post-exposure prophylaxis* - **PEP involves taking antiretroviral drugs after potential exposure** to HIV to prevent infection. It is a treatment, not a primary prevention method. - It is effective in reducing the risk of seroconversion if initiated within 72 hours of exposure but is not a guaranteed prevention strategy and should not be relied upon as the sole method. *Regular STI screening* - **Regular screening for sexually transmitted infections (STIs)** can help identify and treat other STIs that might increase the risk of HIV transmission (e.g., ulcerative STIs). - However, screening itself does not prevent HIV transmission; it is a component of comprehensive sexual health care rather than a direct barrier to HIV infection.

Q: An 18-year-old girl is brought to the emergency department because of a 1-day history of severe headache with photophobia and diffuse myalgias. She is a college student and lives in a dormitory in a large urban area. She has not traveled recently. On arrival, she is lethargic. Her temperature is 39.3°C (102.7°F), pulse is 120/min, and blood pressure is 88/58 mm Hg. Examination shows scattered petechiae and ecchymoses on the trunk and lower extremities. There is decreased range of motion of the neck. Cerebrospinal fluid analysis shows a cell count of 1,600/μL (80% neutrophils) and a lactate concentration of 5.1 mmol/L. Which of the following is most likely to have prevented this patient's condition?

Polysaccharide conjugate vaccine. ***Polysaccharide conjugate vaccine*** - This patient presents with symptoms highly suggestive of **bacterial meningitis** and **septic shock**, likely caused by *Neisseria meningitidis*, given the petechiae, ecchymoses, and rapid deterioration. - A **meningococcal conjugate vaccine** would have provided protection against most common serogroups of *N. meningitidis* (A, C, W-135, Y) and is strongly recommended for college students living in dormitories due to increased risk of transmission. *Intravenous vancomycin* - This is an **acute treatment** for bacterial meningitis, specifically active against *Streptococcus pneumoniae* and some resistant strains. - It would not have **prevented** the condition; preventative measures are typically vaccines or prophylactic antibiotics. *Erythromycin therapy* - Erythromycin is an antibiotic used for various bacterial infections, including atypical pneumonia and some skin infections. - It is **not the primary prophylactic agent** for meningococcal disease and would not have prevented this specific condition. *Doxycycline therapy* - Doxycycline is a broad-spectrum antibiotic used for a range of infections, including tick-borne diseases and certain respiratory infections. - It is **not indicated for the prevention** of meningococcal meningitis. *Toxoid vaccine* - **Toxoid vaccines** protect against diseases caused by bacterial toxins, such as tetanus and diphtheria. - *Neisseria meningitidis* causes disease primarily through direct invasion and immune response to its capsular polysaccharides, not primarily exotoxins, so a toxoid vaccine would not be effective here.

Q: In Africa, vaccination was given in an endemic outbreak area for a specific disease but due to shortage of vaccines, mass chemoprophylaxis treatment was given to people who were not diseased. Which type of prevention is this?

Specific protection. ***Specific protection*** - **Vaccination** directly prevents disease, fitting into the criteria of specific protection. - **Mass chemoprophylaxis** aims to prevent disease in healthy individuals in an endemic area, which is also a form of specific protection. *Rehabilitation* - This involves measures to restore function and well-being after a disease has occurred and caused disability. - It does not involve preventing the initial onset of disease, as described in the scenario. *Health promotion* - Health promotion includes broad interventions like education, lifestyle changes, and environmental modifications to improve overall health and prevent disease indirectly. - It is not as targeted as vaccination or chemoprophylaxis against a specific disease. *Early diagnosis and treatment* - This level of prevention focuses on identifying and treating a disease in its early stages to prevent its progression and complications. - The scenario describes preventing disease in healthy individuals, not treating existing cases.

Q: N95 mask is used for:

aerosol. ***aerosol*** - **N95 masks** are specifically designed to filter out at least 95% of **airborne particles** (aerosols) 0.3 microns or larger. - This level of filtration is crucial for protecting against diseases transmitted via **aerosolized droplets**, such as tuberculosis or COVID-19. *respiratory droplets* - While an N95 mask can filter respiratory droplets, it is primarily designed for smaller **aerosol particles** that can remain suspended in the air. - **Surgical masks** are generally adequate for blocking larger respiratory droplets, preventing splash and splatter. *Dust* - While an N95 mask can filter dust, it is an **overkill** for most common dust exposures. - A simple **dust mask** or even a surgical mask can provide adequate protection against larger dust particles. *in general* - This option is too broad; N95 masks are specifically used when there's a risk of exposure to **aerosolized infectious agents** or **fine particulate matter**. - Their use is typically reserved for settings where **aerosol-generating procedures** are performed or when caring for patients with **airborne diseases**.

Q: What is the incubation period of hepatitis B?

45 - 180 days. ***45 - 180 days*** - The typical incubation period for **Hepatitis B** infection ranges from **45 to 180 days** (approximately 6 weeks to 6 months). - This relatively long incubation period is characteristic of the **Hepadnaviridae family** to which HBV belongs. *1 - 30 days* - This period is generally too short for **Hepatitis B** and is more typical for certain **bacterial or viral respiratory illnesses**. - It does not align with the known epidemiology and viral replication cycle of **HBV**. *2 weeks - 6 months* - While **6 months** falls within the upper range, the lower limit of **2 weeks** (14 days) is generally too short for the typical incubation period of Hepatitis B. - The more precise range starts closer to **6 weeks (42 days)**. *15 - 45 days* - This range is too short for the common incubation period of **Hepatitis B**. - This period is more commonly associated with other viral infections, such as **Hepatitis A**.

Question 1

What is the primary objective of the National STI Control Program?

Accepted Answer

Prevention and control of STI transmission

Answer

Research on new treatments

Answer

Contact tracing only

Answer

Providing free medications

Question 2

A sexually active 16-year-old presents for STI screening with recent assault history, multiple partners, inconsistent condom use. Which comprehensive prevention strategy is most appropriate?

Accepted Answer

HPV vaccination, counseling, PrEP evaluation, and regular screening

Answer

Condoms and annual screening

Answer

Single STI screen and treatment if needed

Answer

Abstinence counseling only

Question 3

A 23-year-old woman is diagnosed with chlamydia. Her partner refuses testing. What contact tracing approach is most appropriate?

Accepted Answer

Expedited partner therapy

Answer

Patient referral only

Answer

Contract referral

Answer

Provider referral only

Question 4

Why is partner notification crucial in STI control?

Accepted Answer

To break the chain of transmission

Answer

To improve compliance

Answer

To track resistance patterns

Answer

To reduce treatment costs

Question 5

What is the most effective method for preventing sexual transmission of HIV?

Accepted Answer

Complete abstinence

Answer

Consistent condom use

Answer

Post-exposure prophylaxis

Answer

Regular STI screening

Question 6

Why is the syndromic approach recommended for managing genital ulcers in resource-limited settings?

Accepted Answer

Because it allows immediate treatment without waiting for lab results

Answer

Because it improves contact tracing

Answer

Because it's more cost-effective than testing

Answer

Because it prevents antimicrobial resistance

Question 7

An 18-year-old girl is brought to the emergency department because of a 1-day history of severe headache with photophobia and diffuse myalgias. She is a college student and lives in a dormitory in a large urban area. She has not traveled recently. On arrival, she is lethargic. Her temperature is 39.3°C (102.7°F), pulse is 120/min, and blood pressure is 88/58 mm Hg. Examination shows scattered petechiae and ecchymoses on the trunk and lower extremities. There is decreased range of motion of the neck. Cerebrospinal fluid analysis shows a cell count of 1,600/μL (80% neutrophils) and a lactate concentration of 5.1 mmol/L. Which of the following is most likely to have prevented this patient's condition?

Accepted Answer

Polysaccharide conjugate vaccine

Answer

Intravenous vancomycin

Answer

Erythromycin therapy

Answer

Doxycycline therapy

Answer

Toxoid vaccine

Question 8

In Africa, vaccination was given in an endemic outbreak area for a specific disease but due to shortage of vaccines, mass chemoprophylaxis treatment was given to people who were not diseased. Which type of prevention is this?

Accepted Answer

Specific protection

Answer

Rehabilitation

Answer

Health promotion

Answer

Early diagnosis and treatment

Question 9

N95 mask is used for:

Accepted Answer

aerosol

Answer

respiratory droplets

Answer

Dust

Answer

in general

Question 10

What is the incubation period of hepatitis B?

Accepted Answer

45 - 180 days

Answer

1 - 30 days

Answer

2 weeks - 6 months

Answer

15 - 45 days

Infectious Diseases — MCQs

Infectious Diseases — MCQs

On this page

Practice by Chapter

Want unlimited practice?